| Company: | Alcobra Ltd. | |||||||||
| Symbol: | ADHD | |||||||||
| Price: | Priced at $8.00 | |||||||||
| Description: | They are an emerging biopharmaceutical company primarily focused on the development and commercialization of a proprietary drug, MG01CI, to treat Attention Deficit Hyperactivity Disorder, or ADHD. | |||||||||
| Trade Date: | 5/22 | |||||||||
| Shares: | 3.125 million | |||||||||
| Type: | IPO | |||||||||
|
||||||||||
| Company: | ChannelAdvisor | |||||||||
| Symbol: | ECOM | |||||||||
| Price: | Priced at $14.00 | |||||||||
| Description: | They are a leading provider of software-as-a-service solutions that enable their retailers and manufacturer customers to integrate, manage and optimize their merchandise sales across hundreds of online channels. | |||||||||
| Trade Date: | 5/23 | |||||||||
| Shares: | 5.8 million | |||||||||
| Type: | IPO | |||||||||
|
||||||||||
| Company: | Constellium Holdco B.V. | |||||||||
| Symbol: | CSTM | |||||||||
| Price: | Priced at $15.00 | |||||||||
| Description: | They are a global leader in the design and manufacture of a broad range of innovative specialty rolled and extruded aluminum products, serving primarily the aerospace, packaging and automotive end-markets. | |||||||||
| Trade Date: | 5/23 | |||||||||
| Shares: | 22.22 million | |||||||||
| Type: | IPO | |||||||||
|
||||||||||
| Company: | Epizyme | |||||||||
| Symbol: | EPZM | |||||||||
| Price: | $13.00-$15.00 | |||||||||
| Description: | They are a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative personalized therapeutics for patients with genetically defined cancers. | |||||||||
| Trade Date: | 5/31 | |||||||||
| Shares: | 4.3 million | |||||||||
| Type: | IPO | |||||||||
|
||||||||||
| Company: | Global Brass and Copper Holdings | |||||||||
| Symbol: | BRSS | |||||||||
| Price: | Priced at $11.00 | |||||||||
| Description: | They are a leading, value-added converter, fabricator, distributor and processor of specialized copper and brass products in North America. | |||||||||
| Trade Date: | 5/23 | |||||||||
| Shares: | 7 million | |||||||||
| Type: | IPO | |||||||||
|
||||||||||
| Company: | Ply Gem Holdings | |||||||||
| Symbol: | PGEM | |||||||||
| Price: | Priced at $21.00 | |||||||||
| Description: | They are a leading manufacturer of residential exterior building products in North America, mainly focused on siding, fencing, stone, windows and doors. | |||||||||
| Trade Date: | 5/23 | |||||||||
| Shares: | 15.8 million | |||||||||
| Type: | IPO | |||||||||
|
||||||||||
| Company: | Portola Pharmaceuticals | |||||||||
| Symbol: | PTLA | |||||||||
| Price: | Priced at $14.50 | |||||||||
| Description: | they are a biopharmaceutical company focused on the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders and inflammation for patients who currently have limited or no approved treatment options. | |||||||||
| Trade Date: | 5/22 | |||||||||
| Shares: | 8.42 Million | |||||||||
| Type: | IPO | |||||||||
|
||||||||||